Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks. Compass Pathways is developing psilocybin as a treatment for depression. Viking ...

Recent reports indicate the US economy experienced negative growth in the first quarter, creating a stark contrast with the stock market’s performance. This economic contraction comes at a time when ...

Occidental Petroleum Corp (NYSE: OXY) is inching higher this morning after Israel launched an airstrike on Iran, resulting in a meaningful increase in oil prices. Brent crude gained as much as 7.0% ...

Procter & Gamble's growth has slowed, with weak cash flow and operational metrics not matching its earnings and sales performance. Despite its defensive profile and dividend history, current valuation ...

Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged a ...